NCT06822829
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy
Clinical trial condition
Indolent B-cell Lymphomas
Explore clinical trials studying Indolent B-cell Lymphomas. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Indolent B-cell Lymphomas trial results
NCT02904577
- Conditions
- Indolent B-cell Lymphomas
- Locations
-
- Vienna Univ Med Int I Vienna, Austria
- Center of Hematology and Hemotherapy, UNICAMP, University of Campinas Campinas, Brazil
- Universidade Federal Do Rio de Janeiro Rio de Janeiro, Brazil
- São Paulo-Santa Casa Medical School São Paulo, Brazil
Completed
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
NCT03329950
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
- Locations
-
- HonorHealth Research Insititute Scottsdale, Arizona, United States
- Northside Hospital, Inc. Atlanta, Georgia, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States